drugset / Trial / NCT01765400
Platelet Inhibition in Patients With Systolic Heart Failure
Phase 4
Completed
30 enrolled
University of Nebraska
Daiichi Sankyo · collabEli Lilly and Company · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The investigators aim to determine if patients with systolic heart failure treated with prasugrel achieve greater platelet inhibition compared to those treated with clopidogrel.
Timeline
- Start
- 2013-05-15
- Primary completion
- 2015-12-01
- Completion
- 2015-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | Oral |
| Comparator | Prasugrel | Small molecule | 10 mg | Oral |